Roche Czech Republic - Pre-Tax Profit Growth

Created with Highcharts 6.0.4%2004200520062007200820092010201120122013201420152016-1000100200300400

Roche CR`s Pre-Tax Profit Growth reached 335 % in 2016. This is 950 % less than in the previous year.

$1.99

Buy Pre-Tax Profit Growth data for Roche Czech Republic.

$19.99

Buy all data for Roche Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Servier Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...           55.9 -37.5 9.53 30.0 -12.4    
... ... ...               27.9 -47.7 20.5 10.1 19.8    
... ... ...               32.4 -25.9 -23.1 -28.4 33.3    
... ...                 208 20.3 -41.4 9.51 89.2    
                    -1.98 -2.34 4.60 70.8 17.6    
... ...                 132 -79.1 198 -6.94 -44.5    
... ... ...               -39.1 -14.2 157 -26.8 -39.4   ...
... ... ... ...             51.8 -18.2 50.6 -98.0 5,393    
... ... ... ... ... ... ... ... ... ... ... ... 6.02 1.33 12.5    
... ... ...               44.2 -91.9 -108 -4,319 -1,273